124 related articles for article (PubMed ID: 31688604)
1. Racial Differences in the Incidence and Survival of Patients With Neuroendocrine Tumors.
Shen C; Gu D; Zhou S; Xu Y; Sarshekeh AM; Halperin D; Shih YT; Yao JC; Dasari A
Pancreas; 2019; 48(10):1373-1379. PubMed ID: 31688604
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
3. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
[TBL] [Abstract][Full Text] [Related]
4. Geographic and demographic features of neuroendocrine tumors in the United States of America: A population-based study.
Gosain R; Ball S; Rana N; Groman A; Gage-Bouchard E; Dasari A; Mukherjee S
Cancer; 2020 Feb; 126(4):792-799. PubMed ID: 31714595
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine tumor epidemiology: contrasting Norway and North America.
Hauso O; Gustafsson BI; Kidd M; Waldum HL; Drozdov I; Chan AK; Modlin IM
Cancer; 2008 Nov; 113(10):2655-64. PubMed ID: 18853416
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics?
White A; Vernon SW; Franzini L; Du XL
Cancer; 2010 Oct; 116(19):4622-31. PubMed ID: 20626015
[TBL] [Abstract][Full Text] [Related]
9. Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.
Allan B; Davis J; Perez E; Lew J; Sola J
Eur J Pediatr Surg; 2013 Oct; 23(5):394-9. PubMed ID: 23444065
[TBL] [Abstract][Full Text] [Related]
10. Racial Differences in Gastroenteropancreatic Neuroendocrine Tumor Treatment and Survival in the United States.
Kessel E; Naparst M; Alpert N; Diaz K; Ahn E; Wolin E; Taioli E; Kim MK
Pancreas; 2021 Jan; 50(1):29-36. PubMed ID: 33370020
[TBL] [Abstract][Full Text] [Related]
11. Characteristics associated with differences in survival among black and white women with breast cancer.
Silber JH; Rosenbaum PR; Clark AS; Giantonio BJ; Ross RN; Teng Y; Wang M; Niknam BA; Ludwig JM; Wang W; Even-Shoshan O; Fox KR
JAMA; 2013 Jul; 310(4):389-97. PubMed ID: 23917289
[TBL] [Abstract][Full Text] [Related]
12. Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002).
Irby K; Anderson WF; Henson DE; Devesa SS
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):792-7. PubMed ID: 16614125
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
14. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in the treatment of early-stage lung cancer.
Bach PB; Cramer LD; Warren JL; Begg CB
N Engl J Med; 1999 Oct; 341(16):1198-205. PubMed ID: 10519898
[TBL] [Abstract][Full Text] [Related]
17. Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.
Metildi C; McLemore EC; Tran T; Chang D; Cosman B; Ramamoorthy SL; Saltzstein SL; Sadler GR
Am Surg; 2013 Oct; 79(10):1068-74. PubMed ID: 24160801
[TBL] [Abstract][Full Text] [Related]
18. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors.
Shi M; Zhou B
Cancer Control; 2021; 28():1073274820986827. PubMed ID: 33491476
[TBL] [Abstract][Full Text] [Related]
20. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus.
Sherman ME; Devesa SS
Cancer; 2003 Jul; 98(1):176-86. PubMed ID: 12833470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]